Sumitomo Pharma Co Ltd 2017 Annual Report with Sustainability Disclosures
The report presents Sumitomo Dainippon Pharma's operational and ESG highlights for the fiscal year ended March 31, 2017. Net sales reached 411.6 billion yen with an operating income of 52.8 billion yen, achieving record results. The group employed 3,572 staff and promoted work style innovations, targeting 10% female managers by 2020. Environmental disclosures for main Japanese operations reported 73,533 tonnes of CO2 emissions, 925 thousand tonnes of water withdrawal, and 8,821 tonnes of waste generated.
Company: Sumitomo Pharma Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2017
Type: Annual Report with Sustainability Disclosures
Pages: 102
Back to company
Sumitomo Pharma Co Ltd
Annual Report
The report presents Sumitomo Dainippon Pharma's operational and ESG highlights for the fiscal year ended March 31, 2017. Net sales reached 411.6 billion yen with an operating income of 52.8 billion yen, achieving record results. The group employed 3,572 staff and promoted work style innovations, targeting 10% female managers by 2020. Environmental disclosures for main Japanese operations reported 73,533 tonnes of CO2 emissions, 925 thousand tonnes of water withdrawal, and 8,821 tonnes of waste generated.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2017
Reporting Period
Apr 1, 2016 - Mar 31, 2017
Fiscal Year
2016
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Energy Consumption
Water Consumption
Total Waste
Women on Board
Women in Management
Employees